Recursion Pharmaceuticals Inc Clas (RXRX)
Total Costs & Expenses
$142.64M
Quarterly · Period ending: · USD
RXRX Total Costs & Expenses
Latest reported$142.64Mperiod ending
Latest reported$142.64Mperiod ending
RXRX Quarterly Total Costs & Expenses ($18.34M → $142.64M)
Quarterly Total Costs & Expenses
High-resolution chart · PNG
RXRX total costs & expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 142,638,000 | |
| 134,977,000 | |
| 143,872,000 | |
| 177,377,000 | |
| 195,330,000 | |
| 206,113,000 | |
| 188,279,000 | |
| 124,436,000 | |
| 114,947,000 | |
| 109,831,000 | |
| 109,554,000 | |
| 109,652,000 | |
| 92,731,000 | |
| 81,999,000 | |
| 74,658,000 | |
| 75,626,000 | |
| 73,844,000 | |
| 61,280,000 | |
| 67,460,000 | |
| 48,902,000 | |
| 43,429,000 | |
| 32,984,000 | |
| 28,132,000 | |
| 23,336,000 | |
| 18,217,000 | |
| 18,343,000 |